Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial
Author:
Funder
Chiesi Farmaceutici S.p.A.
Publisher
Elsevier BV
Reference56 articles.
1. International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy;Carelli;J. Neuro Ophthalmol.,2017
2. Mitochondrial retinopathies;Zeviani;Int. J. Mol. Sci.,2021
3. Inherited mitochondrial optic neuropathies;Yu-Wai-Man;J. Med. Genet.,2009
4. Optic neurodegeneration: Time to act;Gueven;Biol. Med.,2014
5. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation;Riordan-Eva;Brain,1995
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Location and interaction of idebenone and mitoquinone in a membrane similar to the inner mitochondrial membrane. Comparison with ubiquinone 10;Free Radical Biology and Medicine;2024-09
2. Idebenone Treatment for Leber Hereditary Optic Neuropathy: Time to Clinically Relevant Recovery in the LEROS Study;EMJ Neurology;2024-08-13
3. Mitochondria in Retinal Ganglion Cells: Unraveling the Metabolic Nexus and Oxidative Stress;International Journal of Molecular Sciences;2024-08-07
4. Hereditary Optic Neuropathies: An Updated Review;Journal of Clinical & Translational Ophthalmology;2024-06-26
5. Gene therapy for Leber hereditary optic neuropathy;Expert Opinion on Biological Therapy;2024-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3